Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-10-07
1987-10-27
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514302, 514356, A61K 31455, A61K 3144, A61K 3702, C07C10352
Patent
active
047030380
ABSTRACT:
The invention concerns a combination of dihydropyridine derivatives with compounds which inhibit the formation of enzymes which control the conversion of angiotensin I into angiotensin II and their use as antihypertensive agents.
REFERENCES:
patent: 3966946 (1976-06-01), Roe et al.
patent: 3966948 (1976-06-01), Bossert et al.
patent: 3971791 (1976-07-01), Meyer et al.
Garthoff Bernward
Kazda Stanislav
Knorr Andreas
Bayer Aktiengesellschaft
Kight John
Nutter Nathan M.
LandOfFree
Combination of dihydropyridines with angiotensin converting enzy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of dihydropyridines with angiotensin converting enzy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of dihydropyridines with angiotensin converting enzy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1272345